Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Home > products > custom-nanocomposites
> lipid-nanoparticle-composite-materials
> sip4ha2-daunorubicin-cxcr4-liposomes-fam-labeled
SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled)
SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled,particle size<160nm)
Product description
SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled,particle size<160nm) is a multifunctional nanoliposome system that integrates gene interference, chemotherapy drug delivery, active targeting, and fluorescence tracing. It is designed to enhance tumor targeting and synergistic therapeutic effects, and is particularly suitable for malignant tumors with high expression of CXCR4 receptors such as liver cancer and lung cancer.
| Appearance | Freeze-dried powder |
|---|---|
| Solubility | N/A |
| Size | <160nm |
| Drug loading | 7.87%(Doxorubicin) ; 3.64%(SiP4HA2) |
| Encapsulation efficiency | 85.37%(Doxorubicin) ; 91.85%(SiP4HA2) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 3 months |
Document
msds of SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
